UnitedHealth reaffirms 2025 adjusted EPS outlook; Amedisys deal closed in August, modestly dilutive

UNITEDHEALTH GROUP INC

Reaffirmed adjusted 2025 EPS guidance previously issued on July 29, 2025.
Amedisys acquisition closed in August 2025; expected modestly dilutive to adjusted EPS due to financing and integration costs.
Management meeting with investors Sep 8-10, 2025; discussion includes strategy, market positions, and recent results.
No other changes to prior guidance beyond incorporation of Amedisys deal.

item 7.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.